SCHEMBL8801034

SCHEMBL8801034

CCOC(=O)C(CCCNC(=O)OC(C)(C)C)(CCSc1ccccc1)C(=O)OCC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 1/20 0.46
PTPRB P23467 1/20 0.44
NPSR1 Q6W5P4 1/20 0.41
MTNR1A P48039 1/20 0.40
MTNR1B P49286 1/20 0.40
MEN1 O00255 1/20 0.39
GAA P10253 1/20 0.39
KMT2A Q03164 1/20 0.39
CA12 O43570 6/20 0.39
CA1 P00915 6/20 0.39
CA2 P00918 6/20 0.39
CA9 Q16790 6/20 0.39
MALT1 Q9UDY8 1/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HPGD P15428 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5428506 0.82 ALDH1A1 (0.50) MTNR1AMTNR1BMEN1GAAKMT2A
SCHEMBL7528860 0.79 MTNR1A (0.62) IDO1MTNR1AMTNR1BMEN1GAA
SCHEMBL8801039 0.77 LTA4H (0.39) GAANPC1RAB9ASMN1; SMN2HPGD
SCHEMBL8633540 0.77 IDO1 (0.46) IDO1PTPRBNPSR1MEN1GAA
SCHEMBL8329540 0.76 IDO1 (0.50) IDO1PTPRBNPSR1MEN1KMT2A
SCHEMBL8803281 0.75 HDAC3 (0.51) IDO1PTPRBNPSR1CA1CA2
SCHEMBL8799056 0.74 SIGMAR1 (0.51) IDO1PTPRBNPSR1CA1CA2
SCHEMBL31298914 0.73 HPGD (0.55) IDO1MTNR1AMTNR1BMEN1KMT2A
SCHEMBL8633439 0.73 NPSR1 (0.46) IDO1PTPRBNPSR1CA12CA1
SCHEMBL24187607 0.72 TDP1 (0.59) NPSR1MEN1GAAKMT2ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0792878-A2 Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism Dompé S.P.A. (IT) 1997-09-03 EP disclosed